Survival Nomogram for Patients with Upper Tract Recurrence After Resection for Localized Bladder Urothelial Carcinoma

References

• Yuan H , ChenX, LiuLet al. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis. Urol. Oncol.32(7), 989–1002 (2014).
   PubMed Web of Science ®Google Scholar
• Su X , FangD, LiXet al. The influence of tumor size on oncologic outcomes for patients with upper tract urothelial carcinoma after radical nephroureterectomy. Biomed. Res. Int.2016, 4368943 (2016).
   PubMed Web of Science ®Google Scholar
• Habuchi T , TakahashiR, YamadaHet al. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet342(8879), 1087–1088 (1993).
   PubMed Web of Science ®Google Scholar
• Jones TD , WangM, EbleJNet al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin. Cancer Res.11(18), 6512–6519 (2005).
   PubMed Web of Science ®Google Scholar
• Krambeck AE , ThompsonRH, LohseCMet al. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. J. Urol.177(5), 1721–1726 (2007).
   PubMed Web of Science ®Google Scholar
• Cambier S , SylvesterRJ, ColletteLet al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance Bacillus Calmette-Guerin. Eur. Urol.69(1), 60–69 (2016).
   PubMed Web of Science ®Google Scholar
• Aziz A , ShariatSF, RoghmannFet al. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int.117(2), 272–279 (2016).
   PubMed Web of Science ®Google Scholar
• Simone G , BianchiM, GiannarelliDet al. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy. World J. Urol.33(10), 1419–1428 (2015).
   PubMed Web of Science ®Google Scholar
• Seisen T , ColinP, HupertanVet al. Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis. BJU Int.114(5), 733–740 (2014).
   PubMed Web of Science ®Google Scholar
• Roupret M , HupertanV, SeisenTet al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J. Urol.189(5), 1662–1669 (2013).
   PubMed Web of Science ®Google Scholar
• Cha EK , ShariatSF, KormakssonMet al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur. Urol.61(4), 818–825 (2012).
   PubMed Web of Science ®Google Scholar
• Wheat JC , WeizerAZ, WolfJJet al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol. Oncol.30(3), 252–258 (2012).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics.16, 1141–1154 (1988).
   Web of Science ®Google Scholar
• Harrell FJ , LeeKL, MarkDB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med.15(4), 361–387 (1996).
   PubMed Web of Science ®Google Scholar
• Naser-Tavakolian A , GhodoussipourS, DjaladatH. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management. Curr. Opin. Urol.29(3), 189–197 (2019).
   PubMed Web of Science ®Google Scholar
• Picozzi S , RicciC, GaetaMet al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J. Urol.188(6), 2046–2054 (2012).
   PubMed Web of Science ®Google Scholar
• Golabek T , PalouJ, RodriguezOet al. Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guerin immunotherapy? World J. Urol. 35(2), 237–243 (2017).
   PubMed Web of Science ®Google Scholar
• Golabesk T , PalouJ, RodriguezOet al. Long-term bladder and upper urinary tract follow-up recurrence and progression rates of G1-2 non-muscle-invasive urothelial carcinoma of the bladder. Urology100, 145–150 (2017).
   PubMed Web of Science ®Google Scholar
• Yap SA , SchuppCW, ChamieK, EvansCP, KoppieTM. Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes. Urology78(1), 87–92 (2011).
   PubMed Web of Science ®Google Scholar
• Shariat SF , GodoyG, LotanYet al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int.105(12), 1672–1677 (2010).
   PubMed Web of Science ®Google Scholar
• Chromecki TF , EhdaieB, NovaraGet al. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J. Urol.29(4), 473–480 (2011).
   PubMed Web of Science ®Google Scholar
• Roupret M , BabjukM, ComperatEet al. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur. Urol.68(5), 868–879 (2015).
   PubMed Web of Science ®Google Scholar
• Hou G , ZhengY, ZhangLet al. Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma. World J. Urol.38, 1969–1975 (2020).
   PubMed Web of Science ®Google Scholar
• Azemar MD , ComperatE, RichardF, CussenotO, RoupretM. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol. Oncol.29(2), 130–136 (2011).
   PubMed Web of Science ®Google Scholar
• Yates DR , HupertanV, ColinPet al. Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br. J. Cancer106(6), 1083–1088 (2012).
   PubMed Web of Science ®Google Scholar
• Jeldres C , SunM, LughezzaniGet al. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer116(16), 3774–3784 (2010).
   PubMed Web of Science ®Google Scholar
• Ku JH , MoonKC, JungJH, JeongSH, KwakC, KimHH. External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Br. J. Cancer109(5), 1130–1136 (2013).
   PubMed Web of Science ®Google Scholar
• Mbeutcha A , RoupretM, KamatAMet al. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World J. Urol.35(3), 337–353 (2017).
   PubMed Web of Science ®Google Scholar
• Hou G , LiX, ZhengYet al. Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study. Int. J. Clin. Oncol.25(7), 1356–1363 (2020).
   PubMed Web of Science ®Google Scholar
• Liu J , JinJ, YangYet al. Prognostic impact of ALDH1 expression in transitional cell carcinoma of the renal pelvis. Anticancer Res.35(9), 4829–4836 (2015).
   PubMed Web of Science ®Google Scholar
• Simone G , PapaliaR, LoretoAet al. Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int.103(8), 1052–1057 (2009).
   PubMed Web of Science ®Google Scholar